# Survey Study for Velaglucerase Alfa (VPRIV) in Japan

> **NCT03625882** · — · COMPLETED · sponsor: **Takeda** · enrollment: 63 (actual)

## Conditions studied

- Gaucher Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03625882
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-02
- **Primary completion:** 2024-05-14
- **Final completion:** 2024-05-14
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625882, "Survey Study for Velaglucerase Alfa (VPRIV) in Japan". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03625882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*